Auditory Insight

Auditory Insight is an active, specialized strategy consultancy focused exclusively on the hearing healthcare sector. The firm advises CEOs, senior leaders, and investors in pharma, device, and biopharma companies—especially those developing genetic testing, gene therapies, drug therapies, cochlear implants, prescription hearing aids, and OTC hearing aids—on market development and commercialization strategies. Their work has contributed to clients raising over $600M in funding rounds and IPOs as well as securing FDA clinical trial approvals[2][5][7]. They are recognized for proprietary frameworks analyzing the patient journey in hearing healthcare and for deep expertise across all stakeholder groups including patients/advocates, clinicians (audiologists/ENTs), payers/investors[1][4].